Q2 2025 Holdings
Filed 2025-08-14 | 38 holdings | $875.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COMM | 156944100 | $95.4M | 3,670,206 | 10.9% |
| Tango Therapeutics Inc(TNGX) | COMM | 87583X109 | $55.0M | 10,736,000 | 6.3% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $50.0M | 6,964,375 | 5.7% |
| Ocular Therapeutix Inc(OCUL) | COMM | 67576A100 | $49.4M | 5,319,148 | 5.6% |
| Cidara Therapeutics Inc(CDTX) | COMM | 171757206 | $49.0M | 1,005,901 | 5.6% |
| Abivax SA American Depositary Shares(ABVX) | ADRS | 00370M103 | $46.3M | 6,056,596 | 5.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COMM | 03237H101 | $38.1M | 5,943,812 | 4.4% |
| Centessa Pharmaceuticals PLC(CNTA) | ADRS | 152309100 | $38.0M | 2,890,816 | 4.3% |
| Fulcrum Therapeutics Inc(FULC) | COMM | 359616109 | $36.1M | 5,250,000 | 4.1% |
| Dyne Therapeutics Inc(DYN) | COMM | 26818M108 | $35.9M | 3,766,660 | 4.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COMM | 30233G209 | $33.6M | 3,572,335 | 3.8% |
| Upstream BIO Inc(UPB) | COMM | 91678A107 | $30.8M | 2,801,763 | 3.5% |
| Savara Inc(SVRA) | COMM | 805111101 | $28.2M | 12,362,205 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COMM | 252828108 | $28.0M | 1,501,624 | 3.2% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $27.7M | 2,898,103 | 3.2% |
| Disc Medicine Inc(IRON) | COMM | 254604101 | $24.6M | 465,257 | 2.8% |
| Tourmaline BIO Inc(TRML) | COMM | 89157D105 | $23.6M | 1,477,593 | 2.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | COMM | 00847X104 | $23.2M | 697,003 | 2.6% |
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $22.0M | 1,063,000 | 2.5% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $19.3M | 2,452,138 | 2.2% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $17.6M | 3,033,560 | 2.0% |
| Soleno Therapeutics Inc(SLNO) | COMM | 834203309 | $15.6M | 186,250 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COMM | 04635X102 | $14.8M | 2,761,861 | 1.7% |
| Rapt Therapeutics, Inc.(RAPT) | COMM | 75382E208 | $13.1M | 1,636,275 | 1.5% |
| Third Harmonic BIO Inc(THRD) | COMM | 88427A107 | $10.4M | 1,915,424 | 1.2% |
| Enliven Therapeutics, Inc.(ELVN) | COMM | 29337E102 | $10.0M | 498,000 | 1.1% |
| MBX Biosciences Inc(MBX) | COMM | 55287L101 | $7.4M | 650,000 | 0.8% |
| Nektar Therapeutics(NKTR) | COMM | 640268306 | $6.9M | 266,666 | 0.8% |
| Vistagen Therapeutics Inc(VTGN) | COMM | 92840H400 | $5.4M | 2,676,580 | 0.6% |
| Kodiak Sciences Inc(KOD) | COMM | 50015M109 | $4.3M | 1,145,538 | 0.5% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $4.2M | 735,184 | 0.5% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $3.9M | 584,955 | 0.4% |
| Adverum Biotechnologies Inc(AVU0) | COMM | 00773U207 | $3.9M | 1,796,482 | 0.4% |
| Avalo Therapeutics Inc(AVTX) | COMM | 05338F306 | $2.4M | 483,000 | 0.3% |
| Ventyx Biosciences Inc(VTYX) | COMM | 92332V107 | $676.7K | 316,195 | 0.1% |
| Jade Biosciences Inc(JBIO) | COMM | 008064206 | $639.6K | 64,023 | 0.1% |
| Cabaletta BIO Inc(CABA) | COMM | 12674W109 | $131.9K | 86,795 | 0.0% |
| Keros Therapeutics Inc(KROS) | COMM | 492327101 | $0 | 0 | 0.0% |